New frontiers in the oncology of G.I. tract.
Serious, life threatening diseases remain a difficult challenge to conventional treatment methods. In an effort to improve the prognosis of G.I. malignancies, researchers are constantly exploring new treatment modalities. Combined immuno- and chemo-therapy treatment is one such method gaining attention. This article will give a brief background of combined immuno-, chemotherapy treatments, a discussion of one standardized treatment protocol, and a look at the results of the standardized protocol.
Lygidakis
N J
NJ
D003131:Combined Modality Therapy; D003602:Cytotoxicity, Immunologic; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*
D007376:Interleukin-2; D016178:Granulocyte-Macrophage Colony-Stimulating Factor